Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus

Introduction The pathogenesis of neuropsychiatric systemic lupus erythematosus (NPSLE) is widely unknown, and the role of autoantibodies is still undetermined. Methods To identify brain-reactive autoantibodies possibly related to NPSLE, immunofluorescence (IF) and transmission electron microscopy (TEM) on rat and human brains were performed. ELISA was used to reveal the presence of known circulating autoantibodies, while western blot (WB) was applied to characterize potential unknown autoantigen(s). Results We enrolled 209 subjects, including patients affected by SLE (n=69), NPSLE (n=36), Multiple Sclerosis (MS, n=22), and 82 age- and gender-matched healthy donors (HD). Autoantibody reactivity by IF was observed in almost the entire rat brain (cortex, hippocampus, and cerebellum) using sera from NPSLE and SLE patients and was virtually negative in MS and HD. NPSLE showed higher prevalence (OR 2.4; p = 0.047), intensity, and titer of brain-reactive autoantibodies than SLE patients. Most of the patient sera with brain-reactive autoantibodies (75%) also stained human brains. Double staining experiments on rat brains mixing patients’ sera with antibodies directed against neuronal (NeuN) or glial markers showed autoantibody reactivity restricted to NeuN-containing neurons. Using TEM, the targets of brain-reactive autoantibodies were located in the nuclei and, to a lesser extent, in the cytoplasm and mitochondria. Given the high degree of colocalization between NeuN and brain-reactive autoantibodies, we assumed NeuN was a possible autoantigen. However, WB analysis with HEK293T cell lysates expressing or not expressing the gene encoding for NeuN protein (RIBFOX3) showed that patients’ sera carrying brain-reactive autoantibodies did not recognize the NeuN corresponding band size. Among the panel of NPSLE-associated autoantibodies (e.g., anti-NR2, anti-P-ribosomal protein, antiphospholipid) investigated by ELISA assay, only the anti-β2-glycoprotein-I (aβ2GPI) IgG was exclusively found in those sera containing brain-reactive autoantibodies. Conclusion In conclusion, SLE and NPSLE patients possess brain-reactive autoantibodies but with higher frequency and titers found in NPSLE patients. Although many target antigens of brain-reactive autoantibodies are still undetermined, they likely include β2GPI.

[1]  E. Manca,et al.  Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease? , 2021, Clinical Reviews in Allergy & Immunology.

[2]  L. Gonzalez-Lopez,et al.  Seizures in systemic lupus erythematosus: A scoping review , 2021, Seizure.

[3]  M. Govoni,et al.  The management of neuropsychiatric lupus in the 21st century: still so many unmet needs? , 2020, Rheumatology.

[4]  R. Dixon,et al.  Role of Low‐Density Lipoprotein in Early Vascular Aging Associated With Systemic Lupus Erythematosus , 2020, Arthritis & rheumatology.

[5]  Keiko Tanaka,et al.  Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus , 2019, Lupus Science & Medicine.

[6]  G. Vásquez,et al.  Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus. , 2019, Autoimmunity reviews.

[7]  C. Putterman,et al.  Neuropsychiatric lupus: new mechanistic insights and future treatment directions , 2019, Nature Reviews Rheumatology.

[8]  M. Isola,et al.  Melatonin release by exocytosis in the rat parotid gland , 2018, Journal of anatomy.

[9]  M. van Buchem,et al.  Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort , 2018, Lupus.

[10]  M. Lilliu,et al.  Diabetic Status Influences the Storage of Melatonin in Human Salivary Glands , 2018, Anatomical record.

[11]  M. Govoni,et al.  Validity of the Italian algorithm for the attribution of neuropsychiatric events in systemic lupus erythematosus: a retrospective multicentre international diagnostic cohort study , 2017, BMJ Open.

[12]  M. Govoni,et al.  The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. , 2016, Journal of autoimmunity.

[13]  Hsien-Sung Huang,et al.  Neuronal Splicing Regulator RBFOX3 (NeuN) Regulates Adult Hippocampal Neurogenesis and Synaptogenesis , 2016, PloS one.

[14]  S. Sanna,et al.  Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001–2012 , 2016, Lupus.

[15]  Hsien-Sung Huang,et al.  RBFOX3/NeuN is Required for Hippocampal Circuit Balance and Function , 2015, Scientific Reports.

[16]  Paulo Luiz Carvalho Francescantônio,et al.  Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014–2015 , 2015, Front. Immunol..

[17]  N. Inestrosa,et al.  Pathogenicity of Lupus Anti–Ribosomal P Antibodies: Role of Cross‐Reacting Neuronal Surface P Antigen in Glutamatergic Transmission and Plasticity in a Mouse Model , 2015, Arthritis & rheumatology.

[18]  D. Perra,et al.  Twenty-year brain magnetic resonance imaging follow-up study in Systemic Lupus Erythematosus: Factors associated with accrual of damage and central nervous system involvement. , 2015, Autoimmunity reviews.

[19]  Eric H. Chang,et al.  Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-d-Aspartate Receptor , 2015, EBioMedicine.

[20]  L. Caniatti,et al.  Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. , 2015, Rheumatology.

[21]  N. Inestrosa,et al.  Anti–Ribosomal P Protein Autoantibodies From Patients With Neuropsychiatric Lupus Impair Memory in Mice , 2015, Arthritis & rheumatology.

[22]  J. Hanly Diagnosis and management of neuropsychiatric SLE , 2014, Nature Reviews Rheumatology.

[23]  Amanda M. Brown,et al.  Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND) , 2014, Neuroscience Letters.

[24]  S. Cessie,et al.  Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE) , 2014, Lupus.

[25]  Holger Lerche,et al.  RBFOX1 and RBFOX3 Mutations in Rolandic Epilepsy , 2013, PloS one.

[26]  M. van Buchem,et al.  Prospective Study of Clinical Phenotypes in Neuropsychiatric Systemic Lupus Erythematosus; Multidisciplinary Approach to Diagnosis and Therapy , 2012, The Journal of Rheumatology.

[27]  M. van Buchem,et al.  Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. , 2011, Arthritis and rheumatism.

[28]  Eric H. Chang,et al.  Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms , 2010, Proceedings of the National Academy of Sciences.

[29]  S. Kawamoto,et al.  Identification of Neuronal Nuclei (NeuN) as Fox-3, a New Member of the Fox-1 Gene Family of Splicing Factors* , 2009, The Journal of Biological Chemistry.

[30]  J. Chapman,et al.  Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. , 2007, Seminars in arthritis and rheumatism.

[31]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[32]  C. Cocco,et al.  Embedding Media for Cryomicrotomy: An Applicative Reappraisal , 2003, Applied immunohistochemistry & molecular morphology : AIMM.

[33]  K. Schilling,et al.  Developmental and cell type‐specific expression of the neuronal marker NeuN in the murine cerebellum , 2003, Journal of neuroscience research.

[34]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[35]  B. Diamond,et al.  Immunization with a Peptide Surrogate for Double-stranded DNA (dsDNA) Induces Autoantibody Production and Renal Immunoglobulin Deposition , 1998, The Journal of experimental medicine.

[36]  Harvey B Sarnat,et al.  Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system 1 Presented at the XIII International Congress of Neuropathology, Perth, Australia, September 7–12, 1997. 1 , 1998, Brain and Development.

[37]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[38]  Stephen H. Bell,et al.  A ?scoping review. , 2018, Sexual health.

[39]  V. Gusel’nikova,et al.  NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker , 2015 .